United Kingdom

People: PerkinElmer Inc (PKI.N)

PKI.N on New York Stock Exchange

24 Apr 2019
Change (% chg)

$-0.26 (-0.27%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Friel, Robert 

Mr. Robert F. (Rob) Friel is Chairman of the Board, Chief Executive Officer of PerkinElmer Inc. He is no longer President from August 2007 through December 2018. Prior to being appointed President and Chief Executive Officer in February 2008 and Chairman in April 2009, Mr. Friel had served as President and Chief Operating Officer since August 2007, and as Vice Chairman and President of our Life and Analytical Sciences unit since January 2006. Mr. Friel was our Executive Vice President and Chief Financial Officer, with responsibility for business development and information technology in addition to his oversight of the finance functions, from October 2004 until January 2006. Mr. Friel joined PerkinElmer in February 1999 as our Senior Vice President and Chief Financial Officer. Prior to joining PerkinElmer, he held several senior management positions with AlliedSignal, Inc., now Honeywell International. He received a Bachelor of Arts degree in economics from Lafayette College and a Master of Science degree in taxation from Fairleigh Dickinson University. Mr. Friel is currently a director of NuVasive, Inc. and Xylem Inc., and previously served as a director of CareFusion Corporation until its acquisition by Becton, Dickinson and Company in March 2015. He also previously served on the national board of trustees for the March of Dimes Foundation.

Basic Compensation

Total Annual Compensation, USD 9,027,800
Restricted Stock Award, USD 2,765,430
Long-Term Incentive Plans, USD --
All Other, USD 2,168,150
Fiscal Year Total, USD 13,961,400

Options Compensation

  Quantity Market Value
Exercisable 1,070,500 1,633,930.00
Unexercisable 155,500 620,877.00
Exercised 369,191 21,637,200.00
Name Fiscal Year Total

Robert Friel


Prahlad Singh


James Mock


Deborah Butters


James Corbett


Joel Goldberg

As Of  30 Dec 2018